An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)
Public ClinicalTrials.gov record NCT04599972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (the NEAR-2 Study: Near Eye-vision Acuity Restoration)
Study identification
- NCT ID
- NCT04599972
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Orasis Pharmaceuticals Ltd.
- Industry
- Enrollment
- 304 participants
Conditions and interventions
Conditions
Interventions
- CSF-1 Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2020
- Primary completion
- Jan 20, 2022
- Completion
- Jan 27, 2022
- Last update posted
- Apr 3, 2024
2020 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orasis Investigative Site | Chandler | Arizona | 85225 | — |
| Orasis Investigative Site | Mesa | Arizona | 85202 | — |
| Orasis Investigative Site | Phoenix | Arizona | 85032 | — |
| Orasis Investigative Site | Garden Grove | California | 92843 | — |
| Orasis Investigative Site | Mission Hills | California | 91345 | — |
| Orasis Investigative Site | Newport Beach | California | 92663 | — |
| Orasis Investigative Site | Petaluma | California | 94954 | — |
| Orasis Investigative Site | Littleton | Colorado | 80120 | — |
| Orasis Investigative Site | Danbury | Connecticut | 06810 | — |
| Orasis Investigative Site | Delray Beach | Florida | 33484 | — |
| Orasis Investigative Site | Rock Island | Illinois | 61201 | — |
| Orasis Investigative Site | Rochester | New York | 14618 | — |
| Orasis Investigative Site | Kingston | Pennsylvania | 18704 | — |
| Orasis Investigative Site | Cedar Park | Texas | 78613 | — |
| Orasis Investigative Site | San Antonio | Texas | 78229 | — |
| Orasis Investigative Site | Clinton | Utah | 84015 | — |
| Orasis Investigative Site | Draper | Utah | 84020 | — |
| Orasis Investigative Site | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04599972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04599972 live on ClinicalTrials.gov.